Biden Teams Up With Sanders In Battle To Lower Weight Loss Drug Prices
July 3, 2024
Morning Briefing
Read recent pharmaceutical developments in KFF Health News’ Prescription Drug Watch roundup.
Morning Briefing for Wednesday, July 3, 2024
July 3, 2024
Morning Briefing
Unaffordable health care, Alzheimer’s drug, Medicaid ‘unwinding,’ emergency abortion aid, HIV, bird flu, drug costs, and more are in the news.
FDA Approves Second Drug Aimed At Slowing Progression Of Alzheimer’s
July 3, 2024
Morning Briefing
The FDA approved Tuesday Eli Lilly’s early Alzheimer’s treatment. The monoclonal antibody donanemab, which will be sold under the name Kisunla, is designed to clear amyloid in the brain.
Health Care Agencies Reeling After Supreme Court Stunners
July 3, 2024
Morning Briefing
The end of the Supreme Court’s term delivered a series of shocking decision that will have longterm impact on the health care industry as well as federal agencies’ ability to protect public health.
Survey Of People Disenrolled From Medicaid Found Cost, Access Troubles
July 3, 2024
Morning Briefing
A survey of Arkansas, Kentucky, Louisiana, and Texas residents who lost Medicaid coverage once states began reviewing eligibility following the pandemic found that at least half of them were uninsured at the end of 2023. The loss of benefits also led to higher costs for health care or more limited access.
PEPFAR Funding To Be Cut At Least 6% Amid Budget Fight Over AIDS Program
July 3, 2024
Morning Briefing
A senior official for the President’s Emergency Plan for AIDS Relief (PEPFAR) told Politico about the cuts, which the State Department confirmed. The State Department will soon announce its final country-by-country budgets, the State Department spokesperson said.
Providers Must Render Emergency Abortion Aid, Feds Reiterate
July 3, 2024
Morning Briefing
Whether providers offer stabilizing medical care themselves or secure alternate out-of-state care, patients are protected under federal law, the Biden administration says. Separately, abortion ban news from Wisconsin, Arizona, and Texas.
First Edition: July 3, 2024
July 3, 2024
Morning Briefing
Here are today’s early morning highlights from the major news organizations. Note to readers: KFF Health News’ First Edition will not be published July 4-5 in observance of Independence Day. Look for it again in your inbox on Monday. Happy Fourth!
Beyond PMS: A Poorly Understood Disorder Means Periods of Despair for Some Women
By Lauren Peace, Tampa Bay Times
July 3, 2024
KFF Health News Original
Premenstrual dysphoric disorder is estimated to affect around 5% of people who menstruate, but a lack of research and limited awareness of menstrual disorders — even among health care providers — can make getting care difficult.
Lack of Affordability Tops Older Americans’ List of Health Care Worries
By Judith Graham
Updated July 10, 2024
Originally Published July 3, 2024
KFF Health News Original
Rising health care costs are fueling anxiety among older Americans covered by Medicare. They’re right to be concerned.
Potassium Chloride Capsules Recalled For Irregular Heartbeat Risk
July 2, 2024
Morning Briefing
Included in the voluntary recall are 114 batches of Glenmark Pharmaceuticals extended-release capsules. In other news: Only 18% of eligible Americans are up to date on lung cancer screenings; hoarding disorder rises; an anti-noise advocacy group sues the EPA; and more.
Morning Briefing for Tuesday, July 2, 2024
July 2, 2024
Morning Briefing
Doctor shortages, a fake therapist, worker heat protections, generics dispute, abortion ballot measures, pain, covid, and more are in the news.
National Protections For Workers In Extreme Heat Proposed By Biden
July 2, 2024
Morning Briefing
The Biden administration released a proposal that would put in place the first-ever national protections for people who work in extreme heat. The measure, if finalized, would require rest breaks and access to shade and water.
FTC Investigating Teva Over Contested Patents On Inhalers
July 2, 2024
Morning Briefing
The Federal Trade Commission has ordered Teva Pharmaceuticals to provide internal documents about its patents on asthma and COPD inhalers. The move is part of a larger dispute over minor tweaks made by pharmaceutical companies to products to fend off generics competition, resulting in higher prices for patients.
Biden Administration Allocates $206M To Address Shortage Of Geriatricians
July 2, 2024
Morning Briefing
The money will go toward academic programs that focus on training doctors to care for the elderly. Family members and caregivers also may benefit from initiatives to help them care for aging loved ones. Meanwhile, news moms are suing for the right to breastfeeding pump breaks.
Not-For-Profit Hospital In Pennsylvania Hacked By Ransomware Gang
July 2, 2024
Morning Briefing
The group behind the hack of the 114-bed, not-for-profit Wayne Memorial Hospital claimed it had data that it would leak soon. A data breach at Geisinger, meanwhile, is now expected to have affected the personal info of more than 1.2 million people.
Nebraskans Call Out Sneaky Language On Abortion Petitions
July 2, 2024
Morning Briefing
The Secretary of State’s office has received a slew of affidavits from voters who want their names removed from petitions. The majority stem from a petition by Protect Women and Children, which wants the 12-week abortion ban codified in the constitution. In Kansas doctors challenged a law requiring they collect data on patient’s reasons for abortions.
Wyoming’s Ban On Transgender Minor Care Takes Effect
July 2, 2024
Morning Briefing
Puberty blockers and hormone therapy for transgender youth are now restricted in Wyoming. Meanwhile, in West Virginia, students on university and college campuses are allowed to carry guns. In Mississippi, a law restricting young people’s social media use was blocked.
That Bout With Covid Might Cause Myriad Ailments Later On, Study Finds
July 2, 2024
Morning Briefing
Scientists suspect inflammation is at least partly responsible for IBS, mini strokes, and a host of other issues that begin years later, even if a person had only a mild infection. Separately, although the threat of bird flu in humans is low, scientists warn that could change rather quickly.
